cian treating the patient is challenged by a hemorrhagic and an ischemic risk, both with potentially devastating neurological consequences. However, this association is poorly studied in the medical literature. The only available data showed a BCVI incidence of 3.9% in a subgroup of head-injured patients (isolated cranial fractures with or without intracranial hematoma). 24 The main objective of this study was to describe the incidence and characteristics of BCVI in patients with severe TBI.
Methods

Study Design and Patient Selection
We conducted a 7-year prospective, observational, single-center study at the Sainte Anne Military Hospital of Toulon, France. Between January 2007 and December 2013, all intubated patients with TBI admitted to the ICU were eligible. Inclusion criteria were as follows: patients older than 18 years who had severe TBI, defined as a minimum Glasgow Coma Scale (GCS) score of ≤ 8 after resuscitation. Patients suffering from penetrating trauma and those in whom no CT scan was obtained within the first 24 hours were excluded from the study.
All patients were sedated, intubated, and received mechanical ventilation in accordance with the international guidelines and with the following objectives: head elevation 30°, PaO 2 > 85 mm Hg, PaCO 2 between 35 and 45 mm Hg, natremia between 140 and 145 mEq/L, targeted temperature < 37.5°C, intracranial pressure (ICP) < 20 mm Hg, and cerebral perfusion pressure > 60 mm Hg. If ICP increased, the protocol included moderate hypocapnia (PaCO 2 between 30 and 35 mm Hg), increase of sedation with propofol, muscle paralysis with cisatracurium, and moderate hypothermia (34°C-35°C). Third-line therapy included barbiturate infusion and/or unilateral craniectomy. [9] [10] [11] [12] [13] [14] The institutional review board approved the study and waived the requirement for informed consent from the patient or patient's next of kin, given the observational nature of the study.
Data Collected and Diagnostic Modalities
Patient characteristics, mechanisms of injury, initial GCS score, results of whole-body CT scan, location and grade of BCVI, timing and type of initial therapy, followup imagery, evolution of the disease, in-hospital mortality, and outcome according to the Glasgow Outcome Scale (GOS) at 6 months and 1 year were collected. A thoracic trauma included all chest lesions except for thoracic vertebral fractures.
Primary screening of BCVI was done using a 64-channel CT scanner with CT angiography (CTA) (General Electric Medical Systems). Patients were positioned with their arms down to the side and underwent head and cervical spine studies without contrast. Scout images were obtained and the carotid vessels identified. Radiopaque iodinated contrast dye injection at 4 ml/sec was given (Omnipaque 65 ml). When a contrast blush was noted at the origin of the carotid arteries, the CTA head/neck scan was initiated from the clavicles and continued to the apex of the calvaria. Images were acquired at 0.625-mm-thick slices and 0.625-mm intervals. If necessary, patient wholebody imaging was completed. Digital reconstruction was performed immediately after the completion of CT scans. Sagittal and coronal images were reconstructed at 2-mm by 2-mm intervals, whereas axial images were at 1-mm by 1-mm intervals.
In the situations indicated by the institutional protocol, digital subtraction angiography (DSA) (Philips Healthcare) was performed by an experienced neuroradiologist. Selective single-plane DSA of the aortic arch and each of the subclavian arteries, and biplanar 4-vessel DSA of the cerebrovascular arteries were performed. The attending neuroradiologist's interpretations of CTA and/or DSA were used to determine BCVI location and grade according to the Biffl et al. grading scale. 7 Grade I injuries were defined as irregularity of the vessel wall or a dissection ≤ 25% luminal stenosis. Grade II injuries included an intraluminal thrombus, intimal flap, or dissections or intramural hematomas with > 25% luminal stenosis. Grade III injuries were pseudoaneurysms. Grade IV injuries were vessel occlusions. Grade V injuries were complete vessel transection with free contrast extravasation or arteriovenous fistulas.
Treatment Methods
Patients in whom BCVI was diagnosed were treated with systemic anticoagulation (unfractionated heparin or low-molecular-weight heparin [LMWH] ). The beginning point and type of systemic anticoagulation were chosen at the discretion of the treating physician, while respecting the benefit-risk ratio. In the case of unfractionated heparin, partial thromboplastin time was maintained at 45-60 seconds. In case of LMWH, anti-factor Xa activity was maintained at 0.4-0.6 IU/ml. A small number of patients received no systemic treatment due to endovascular treatment, major bleeding risk, or withdrawal of care.
Study End Points
The primary end point of this study was to determine the incidence of BCVI after severe TBI. Secondary end points were to determine risk factors of BCVI in this population and to describe the evolution of the disease in patients with BCVI.
Statistical Analysis
Statistical analysis was performed with XLSTAT version 2015.3.01 (Addinsoft). Continuous data were reported as the mean ± SD, or the median with the interquartile range (IQR) (25th-75th percentile) when data were not normally distributed. Nominal variables are reported as numbers and proportions (%).
For this observational study with consecutive sampling, a = 0.05, b = 0.2, and an estimated incidence of 4% for BCVI after severe TBI, we planned to include at least 191 patients to yield an expected incidence rate of 5%. 24 A univariate analysis was conducted using the chisquare test or Fisher's exact test to compare categorical variables, and the Mann-Whitney test or Student t-test to compare groups for continuous variables (for comparison of medians and comparison of means, respectively). In-dependent factors associated with BCVI were identified using a logistic regression model. All parameters with p value < 0.05 on univariate analysis and clinical relevance were included in the multivariate regression model. The Hosmer-Lemeshow goodness-of-fit test and the area under the receiver operating characteristic (ROC) curve were used to evaluate the overall fit of the final model. The final model expressed the odds ratio and 95% confidence intervals. For all tests, p < 0.05 was considered statistically significant.
Results
Patient Population
During the study period, 243 intubated patients with TBI were admitted to the ICU. Fifteen patients were excluded: 10 due to mild or moderate TBI (minimum GCS score of > 8 after resuscitation); 4 due to penetrating trauma; and 1 due to the absence of a CTA study obtained within the first 24 hours. The remaining 228 were included. The most common mechanism of injury was motorcycle crash (30.1%) (Fig. 1) . The median age of the population was 37 years (IQR 23-55 years), the median Injury Severity Score (ISS) was 24 (IQR [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , and the median initial GCS score was 6 (IQR 4-8). There were 179 male (78.5%) and 49 female (21.5%) patients.
Blunt Cerebrovascular Injuries
A BCVI was detected in 21 patients. These included 15 patients (71%) with carotid artery injury (CAI), 5 (24%) with vertebral artery injury (VAI), and 1 (5%) with injury to both of them. The incidence of BCVI was 9.2% of all admissions for severe TBI. A CAI occurred in 19 vessels (7 left, 6 right, and 3 with bilateral lesions). A VAI occurred in 6 arteries (2 left, 4 right). The majority of injuries were dissections (Grade I or II injuries): 17 vessels (68%). Table 1 provides the location and grade of detected injuries.
Comparisons of patients with and without BCVI are displayed in Table 2 . Notably, patients with BCVI were more severely injured, with a median ISS of 41 (IQR 29-50) versus 22 (IQR 16-32) (p < 0.0001) for those without BCVI. Patients with BCVI also had initial hemodynamic shock and/or hypoxia (SpO 2 < 90% during > 5 minutes) more frequently: 12 of 21 (57%) versus 44 of 207 (21%) (p = 0.0002), and 9 (43%) versus 29 (14%) (p = 0.001), respectively. The number and type of intracranial lesions were comparable between the groups. However, associat- (28) 10 (40) 2 (8) 3 (12) 3 (12) 25 (100) ed lesions were more frequent in patients with BCVI (90% vs 66%, p = 0.02). Patients with BCVI had more thoracic trauma (90% vs 45%, p < 0.0001), cervical spine injuries (43% vs 8%, p < 0.0001), and hepatic lesions (24% vs 3%, p < 0.0001). Initial GCS scores were lower in patients with BCVI: median 4 (IQR 3-6) versus 7 (IQR 4-9) (p = 0.005).
The predominant mechanism of injury in the BCVI group was motorcycle crash (57% vs 28%, p = 0.005).
Risk Factors for BCVI
After multivariate logistic regression analysis, major significant predictors of BCVI were as follows: motorcycle crash (OR 8.2; 95% CI 1.9-34.8, p = 0.004); fracture involving the carotid canal (OR 11.7; 95% CI 1.7-80.9, p = 0.01); cervical spine injury (OR 13.5; 95% CI 3.1-59. 
Treatment, Stroke Rate, and Hemorrhagic Complications
Four of the 21 patients with BCVI died prematurely before definitive treatment; these individuals had significant associated injuries. Among the 17 survivors, 14 patients (82%) had medical treatment with systemic anticoagulation therapy. Four patients received unfractionated heparin and 10 had LMWH. The beginning of systemic anticoagulation was at a median of Day 1.5 (IQR Day 1-4). Seven patients (41%) were treated with systemic anticoagulation within the first 24 hours after admission. Two patients (12%) had endovascular interventions with coils (for treatment of Grade III right CAI and Grade V bilateral CAI, respectively). One patient (6%) had just chemoprophylaxis for deep vein thrombosis started at Day 5 (Grade I right VAI with severe ICH). Four patients with BCVI suffered an ischemic stroke, for an overall stroke rate of 19%. One stroke was present on arrival (Grade IV left CAI), 1 developed before introduction of systemic anticoagulation therapy (Grade II right CAI), and 2 developed despite early anticoagulation therapy (2 patients with Grade II left 
Posttreatment Outcomes
Clinical follow-up was not different between patients with and those without BCVI, in terms of intracranial hypertension episodes, use of barbiturate or therapeutic hypothermia, or number of decompressive craniectomies ( Table 4 ). The mortality rate was comparable between the groups: 33% in patients with versus 26% in patients without BCVI (p = 0.48). The incidence of poor outcome (defined as a GOS score between 1 and 3) was not different at 6 months and 1 year between patients with or without BCVI: 50% versus 45% (p = 0.66) and 47% versus 43% (p = 0.7), respectively.
Discussion
To our knowledge, this article is the first to focus on BCVI in patients with severe TBI. Our results highlight a rate of 9.2% for BCVI in this particular population. BCVI is increasingly recognized, due to advancements in screening and imaging technology. In the recent literature, the incidence of BCVI in all patients with blunt trauma has increased from 0.1% to 1.7%. 4, 8, 15, 24, 25, 27, 31, 35 It is now recognized that patients with facial fractures, cervical spine injury, or thoracic lesions have an increased risk of BCVI. 4, 25, 32 Our study strongly suggests that patients with severe TBI are a very high-risk population for BCVI. This is probably due to common physiological mechanisms. Indeed, the main mechanisms of BCVI are the following: hyperextension with contralateral rotation of the head, laceration of the artery by adjacent fractures, direct blow to the neck, and direct intraoral trauma with a hard object. 7, 16, 17, 26, 34 These mechanisms generally result from a high-speed deceleration crash with cervical hyperextension or hyperflexion, or direct blunt trauma to the neck, face, head, or upper chest. For TBI, similar mechanisms of injury exist: impact-in which the immediate force makes contact with the skull and leads to injury; and impulsein which a force causes head movement without directly acting upon the head. 3 Moreover, in our study, patients with severe TBI frequently had injuries to the upper body: facial fractures (103/228; 45%), cervical spine injuries (25/228; 11%), and thoracic lesions (113/228; 50%). All of these can explain the very high incidence of BCVI found in this population.
The main risk factors of BCVI after severe TBI are fracture involving the carotid canal, cervical spine injury, and thoracic trauma. This is consistent with the literature. 4, 25, 27, 30 In fact, Franz et al. demonstrated that cervical spine and thoracic injuries are significantly associated with BCVI in all blunt trauma admissions (OR 5.45 and 1.98, respectively). 25 We also found new significant predictors of BCVI: ISS and, surprisingly, hepatic lesions. This is certainly reflecting the violence of the crash. This hypothesis is confirmed by the fact that a motorcycle crash is also an independent risk factor for BCVI. However, 2 wellestablished predictors of BCVI were not retrieved: basilar skull fracture and initial GCS score. 4, 27 This is probably due to the particular population of the study. Indeed, only patients with severe TBI (GCS score of ≤ 8) were included. This limits the power of the study to recognize GCS score as an independent risk factor. Concerning basilar skull fractures, they are too frequent in our population (21%) to find a significant difference in multivariate analysis.
Untreated vascular injuries could have an overall stroke rate approaching 40%-60%, with a stroke-related mortality as high as 50%. 4, 18, 22, 35 It is now well established that medical therapy (with anticoagulation or antiplatelet agents) that is started before the onset of neurological symptoms could reduce the occurrence of neurological events by a factor of 6. 28, 35 The stroke rate could be as low as 4% in treated patients. 28, 35 Consistent with other studies, our overall stroke rate was 19%, despite the frequent and early use of anticoagulation therapy. Some could have doubts concerning the safety of this therapy in patients with severe TBI. Recently, Callcut et al. examined the safety and efficacy of early pharmacological treatment for patients with both BCVI and traumatic neurological injury, including TBI and/or spinal cord injury. 18 They found that early medical therapy significantly reduces the stroke rate (from 57% to 4%), without increasing the risk of ICH expansion (from 5% to 6%). However, pharmacological treatment was only initiated at a median of Day 3, and their patient population was different, including individuals with mild or moderate TBI.
In our study, anticoagulation therapy was started sooner, at Day 1.5, and 41% of patients were treated on arrival in the ICU. We chose to perform this therapy early because the latent period between injury and ischemia was observed mostly within 10-72 hours. 8, 29 Despite this very early therapy, only 1 ICH was reported following an ICP monitoring. There was no hemorrhagic deterioration of initial lesions due to pharmacological exposure. The literature demonstrated no difference in the efficacy of antiplatelet and anticoagulation therapies at preventing stroke in patients suffering from BCVI. 28 In our institution, systemic anticoagulation is preferred for 2 reasons: 1) its effects can be easily monitored (by partial thromboplastin time or anti-factor Xa activity); and 2) in case of hemorrhagic complication or emergency surgery, this therapy can be quickly counteracted by the administration of protamine sulfate.
Study Limitations
Our study had several limitations. First, the relatively small number of patients with BCVI limits the power of the multivariate analysis. Second, our results cannot be transposed to all ICUs or trauma centers, due to the singlecenter recruitment. Finally, CTA by 64-channel multidetector scanner was used for diagnosing or excluding BCVI. A previous study using 32-channel CTA showed an inadequate sensitivity of 51% compared with DSA. 22 However, compared with the 32-channel CT scanner, Paulus et al. recently highlighted that 64-channel CTA demonstrated a significantly improved sensitivity of 68%. 33 Specificity and negative predictive value were 92% and 97%, respectively. Despite better results with the 64-channel CTA, we could have missed a certain number of patients with true BCVI in our study population, and therefore the true incidence may be higher. However, Paulus and colleagues found that 62% of the false-negative findings involved low-grade injury (Grade I). 33 These low-grade injuries probably have a lower impact in patients and are rarely complicated by neurovascular events. Indeed, Biffl et al. highlighted their finding that two-thirds of mild intimal injuries (Grade I) healed at Day 7, regardless of therapy. 7 Thus, our results seem to stay relevant in daily practice.
Conclusions
Despite these limitations, the present work is, to our knowledge, the first designed to evaluate the incidence of BCVI in patients with severe TBI. In this particular population, the incidence of BCVI was very high, approximately 9%. The main risk factors reflected high-velocity injuries like those sustained in motorcycle crashes or leading to hepatic lesions; or were related to cervical artery proximity injuries such as fractures involving the carotid canal or cervical spine injuries. In addition, our study demonstrates that early administration of medical therapy could be safe. However, prospective randomized multicenter studies are mandatory to confirm this last point.
